for Sep 05, 2020 through Sep 11, 2020
NEW 🔥🔥#ofid by 🌟s @stoverkr @BBookstaver_USC @blandman19@klusardi41
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 8, 2020
Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2019. #IDTwitter https://t.co/i9fFh0wapz pic.twitter.com/O11Raiw4Gx
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he is cautiously optimistic that a Covid-19 vaccine will be proven safe and effective by the year's end. But he said that’s unlikely to happen by Election Day. https://t.co/5xZw7sQZ4G
— CNN (@CNN) September 8, 2020
Attached a wonderful figure from my @BrighamWomens colleagues in infection control, just published. So important. https://t.co/VJfOvGJZFR https://t.co/J9vWlZQKoh pic.twitter.com/75pgnMe1B5
— Paul Sax (@PaulSaxMD) September 5, 2020
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in... https://t.co/FZot2a5upO via @statnews. We will need more information but obviously this is concerning.
— Carlos del Rio (@CarlosdelRio7) September 8, 2020
Viral load of #SARSCoV2 across patients & compared to other respiratory viruses.
— Microbes&Infection (@MicrobesInfect) September 8, 2020
Article discusses importance of viral load to predict contagiousness & to assess disease progression.https://t.co/vGqcjGhx9v #coronavirus #flu #influenza #COVID19 pic.twitter.com/yQGoKlcG8Z
Fauci warns US needs to 'hunker down' for fall, winter: 'It's not going to be easy' https://t.co/jq4eFstAKQ The director of the National Institute of Allergy and Infectious Diseases went on to warn against underestimating the pandemic's potential to cause continued destruction.
— Tom Lasseter (@TomLasseter) September 11, 2020
NEW🔥🔥🔥 h/t @SIDPharm@pranita_tamma @OncIDPharmd @davidvanduin @ClancyNeil@IDSAInfo Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. CRE PSA ESBL #IDTwitter https://t.co/kPfcgV8uiW pic.twitter.com/2a7mxNQbF8
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 8, 2020
Misuse or overuse of antibiotics has resulted in widespread #antimicrobialresistance (AMR), which could be made much worse by COVID-19.
— IDSA (@IDSAInfo) September 8, 2020
IDSA's new AMR Guidance offers advice for the clinical treatment of three of the most common drug-resistant pathogens: https://t.co/MbXuGRov5U
Covid-19 has interfered with care for other diseases, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. “Unfortunately, it’s been disruptive across the board, not only in the United States but globally." https://t.co/QQX9GqOpgd
— CNN (@CNN) September 8, 2020
Frustrated with biased #COVID19 coverage re Africa in “western countries”... “Prof of Infectious Diseases & Microbiology from Algeria, Morocco, Senegal, Niger, Mali, Mauritania, Gabon” break their silence re African countries’ vast use of CLQ/HCQ +/- AZM
— Kulvinder Kaur MD (@dockaurG) September 11, 2020
▶️https://t.co/JTB0uXSknj
"Professor Moussa Seydi, head of the infectious diseases department at Fann hospital in Dakar, confirmed that the use of hydroxychloroquine with the antibiotic azithromycin is effective for early stage cases." https://t.co/wNzDzP7zJn
— AssocAmerPhys&Surg (@AAPSonline) September 5, 2020
Microbiology Monday: A new review in #MMBRJournal highlights the complexities of biofilm formation and regulation in Staphylococcus aureus and Staphylococcus epidermidis https://t.co/MvSQM7y2nd pic.twitter.com/nl3wd1jBcL
— ASM (@ASMicrobiology) September 7, 2020
Please RT!
— Ben Ashby (@bnashby) September 11, 2020
2-year #postdoc @UniofBath to theoretically study the eco-evolutionary dynamics of age-specific resistance to infectious diseases & more!
Application deadline: 12th October 2020.
Details: https://t.co/mHdJmHtT6f@MilnerCentre @BES_Parasite @FindAPostDoc
Director of the National Institute of Allergy and Infectious Diseases Anthony S. Fauci discussed COVID-19 vaccine progress and the United States’ response to the pandemic in a talk at the Harvard Medical Grand Rounds on Thursday morning. https://t.co/Qn8TmyTT0r
— The Harvard Crimson (@thecrimson) September 11, 2020
Moderna slows coronavirus vaccine trial to ensure minority representation https://t.co/KMaYekfng2 “Rather we have higher diverse participants and take one extra week," @moderna_tx CEO Bancel said. Diversity "matters more to us than speed."
— Carlos del Rio (@CarlosdelRio7) September 8, 2020
Bacterial and fungal superinfections in critically ill #COVID19 patients authored by 🌟s @yourICM
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 10, 2020
⭐Fantastic figure showing Building blocks of the current uncertainty in estimating the true risk of bacterial and fungal superinfections⭐https://t.co/NpMZ0p2M0S pic.twitter.com/gCRu1IeJWX
NEW 🔥#IJAA @MaryElizabeth81 @dana_nelson21 @jlbouchard001 @julie_justo @alyssapgould @BBookstaver_USC
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 9, 2020
The use of continuous infusion ceftolozane/tazobactam for resistant G - ve bacterial infections:a retrospective analysis &brief review of literature https://t.co/mIu9dW9NcG pic.twitter.com/UOVc6XhqFv
Researchers develop a compound that can kill both gram-positive & gram-negative antibiotic-resistant bacteria.
— Microbes&Infection (@MicrobesInfect) September 5, 2020
Doctors have not had a new treatment for gram-negative bacteria in 50 years, & no potential drugs have entered clinical trials since 2010.https://t.co/g3uQzkgdZa
🔥Very happy to be invited by the European Society of Infectious Diseases and Clinical Microbiology @ESCMID at #ECCVID (ESCMID Conference on Coronavirus Disease) to talk about
— Nathan Peiffer-Smadja (@nathanpsmad) September 10, 2020
⚠️Hydroxychloroquine against SARS-CoV-2: pros and cons
Registration still openhttps://t.co/4O9sjYPfJJ pic.twitter.com/3iAjpZlVmx
NEW 🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 8, 2020
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET). #CID #IDTwitter https://t.co/DhiFHsnvMZ
A novel treatment option for a tremendously challenging infection -- some early experience here. Great work led by our superstar ID PharmD @jeffpears0n
— Paul Sax (@PaulSaxMD) September 9, 2020
Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series https://t.co/kXuGfSu34Y pic.twitter.com/0f47y4efOq
#COVID19 patients have active & prolonged gut viral infection, even in the absence of gastrointestinal symptoms, new study showed.
— Microbes&Infection (@MicrobesInfect) September 7, 2020
The #coronavirus may continue to infect & replicate in the digestive tract even after clearing in the airways.https://t.co/PX56jwQkMa
Nemo’s 🐠 Pills
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 7, 2020
Though infrequent,consumption of antibiotics intended for fish use for self-medication is alarming
A new study @BBookstaver_USC examined the availability of OTC fish Abx online&the documented intent for self-medication #IDTwitter @marynmckhttps://t.co/fswaDpRSmh pic.twitter.com/E3ue11QZc3
Congratulations @pranita_tamma @OncIDPharmd @davidvanduin @ClancyNeil and #twitterless Drs. Mathers and Bonomo on publishing the @IDSAInfo Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections!!
— Erin McCreary (@ErinMcCreary) September 8, 2020
https://t.co/SAsO0mjee9
🔥Interesting🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 6, 2020
The results of this study @LancetMicrobe indicate that previous infection wit rhinovirus inhibits infection with influenza A virus by activating antiviral defences in the target tissue of both viruses the human airway epithelium #IDTwitter https://t.co/6KL2Sfx14X
Hot off the press, our case series of omadacycline for Mycobacterium abscessus published in OFID. Thanks to @jeffpears0n for leading the effort and to @AaronRichterman @zoeweissMD @FranciscoMarty_ @PaulSaxMD @sigal_md, Gustavo Velasquez, and Sam Vidal! https://t.co/0lQ7KB7yiQ
— Brandon Dionne (@BWDionne) September 9, 2020
I want this to be a regular series, and include other areas, like infection prevention. Modified Delphi technique used to select the top antimicrobial stewardship papers of 2019: https://t.co/l7r1DU3OHJ
— Michael Calderwood (@CalderwoodMD) September 10, 2020
"... with Ct above 33 to 34 are not contagious and can be discharged from hospital care or strict confinement, according to a brief report published in the European Journal of Clinical Microbiology & Infectious Diseases"
— SecondOpinion (@DaFeid) September 10, 2020
May, refered study late April ...https://t.co/JYpj5rgWYb
Cohort Study: Vitamin D and risk of COVID-19 https://t.co/zAuOIghPW4
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 🤚 🧼😷 (@eliowa) September 5, 2020
Zinc is an essential mineral. It has long been known for its beneficial effects on immune health. On top of regulating immune function, zinc also aids in fighting infectious diseases like the flu and pneumonia. This is the zinc supplement I recommend: https://t.co/OrVV7wXgch #ad pic.twitter.com/ylmhhxf6jq
— Esoteric Exposal (@EsotericExposal) September 8, 2020
Public health used to be about fighting infectious diseases. But long ago the public-health set grew tired of that tedious business and began lecturing us about inequality and eating too much chocolate. No wonder they fluffed this pandemic, says @cjsnowdonhttps://t.co/Z1TmaROzfx
— spiked (@spikedonline) September 5, 2020
Covid-19 has interfered with care for other diseases, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. “Unfortunately, it’s been disruptive across the board, not only in the United States but globally." https://t.co/dM2jSMnfdr
— CNN International (@cnni) September 8, 2020
Just in! @IDSAInfo treatment guidelines for infections caused by MDR GNRs, co-authored by @SIDPharm member @OncIDPharmd! #IDTwitter
— SIDP (@SIDPharm) September 8, 2020
Check out the full guidelines here: https://t.co/R6AKOpHQAp pic.twitter.com/kOskKwv0MY
The #coronavirus targets lungs but also kidneys, liver & blood vessels. About 1/2 of patients report neurological symptoms, such as headaches, confusion, delirium.
— Microbes&Infection (@MicrobesInfect) September 9, 2020
New study offers clear evidence that in some people, the coronavirus invades #brain cells.https://t.co/twp2a0WPYp
More good news on the PPE works front. “...overall risk of hospital-acquired COVID-19 was low and that rigorous infection control measures may be associated with minimized risk” https://t.co/hYd9Yiktr7
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 🤚 🧼😷 (@eliowa) September 11, 2020
🔥BiRT🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 10, 2020
A new open label RCT (n=&200) #CMI whether antibiotics are effective in ⬇️ the occurrence of symptomatic UTI in kidney transplant recipients with ASB > 2 months post-transplantation NO significant difference in occurrence of symp UTI #IDTwitterhttps://t.co/YeJEum2tYo
Should #AntimicrobialStewardship programs be involved in restricting #ConvalescentPlasma for #COVID-19? Here are our thoughts in @ICHEJournal!
— Mike Stevens (@Dr_Mike_Stevens) September 9, 2020
I always learn a ton from @Payal_Patel & @BronxASP & hope this will be useful to the #IDTwitter community https://t.co/0twRplKWeO pic.twitter.com/FmYsLa9teJ
“If you thought Covid was bad, you don’t want anti-microbial resistance. I don’t think I’m exaggerating to say it’s the biggest human health threat, bar none. Covid is not anywhere near the potential impact of AMR.” https://t.co/qeNv867BQN #StopSuperbugs
— Antibiotic Action (@TheUrgentNeed) September 10, 2020
In the syntrophy between Clostridium ljungdahlii and C. acetobutylicum, the cell walls and membranes fuse between the two organisms. Transmission electron microscopy shows a large-scale exchange of proteins between the organisms. @mBioJournal https://t.co/WfW4mdt6vg pic.twitter.com/rHC6zvEL3f
— ASM (@ASMicrobiology) September 7, 2020
How deforestation is leading to more infectious diseases in humans due to native animals migrating for survival. This article from November 2019 warned how scientists were fearing the next deadly pandemic could emerge from what lives within the forests https://t.co/pQHDsXsLJ6 pic.twitter.com/TOMERcTkK3
— Massimo (@Rainmaker1973) September 9, 2020
A large retrospective cohort analysis of EHR data from 131 US hospitals @TheLancetInfDis
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 9, 2020
1 in 5 patients with BSI received discordant empirical Abx, Receiving discordant empirical Abx therapy was associated with ⬆️ odds of mortality overall. #IDTwitter https://t.co/Kph9SVKE3Y pic.twitter.com/VQPOmstinu
A new prospective cohort study in #CMI
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 6, 2020
🕟💉🤒🎯
Administration of antibiotics within 4 hours of admission had NO significant effect on the outcomes in patients with CAP. #IDTwitter https://t.co/y3bNMr11g7
New research Article: Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals https://t.co/hOVGDImJwW
— The Lancet Infectious Diseases (@TheLancetInfDis) September 9, 2020
Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa | Clinical Infectious Diseases | Oxford Academic
— Kerrin Begg (@KerrinBegg) September 5, 2020
A privilege to be part of this incredible collaborative
@UCTHealthSci
@UCT_news https://t.co/e0sDUwzct5
🔥Breaking news🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 8, 2020
How close are we to the approval of the first oral #Carbapenem
Spero Announced Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in cUTI & Acute Pyelonephritis
Tebipenem is non inferior IV Ertapenemhttps://t.co/2Y4a1NC9tt
Popular press version: @SturgisRally linked to 20% of US #coronavirus cases in August; generated public health costs of approximately $12.2 billion. Because..that's how infectious diseases work with mass gatherings events. Like Colleges are any different.https://t.co/W4puE51NIC
— Dr. Ali Khan (@UNMC_DrKhan) September 8, 2020
🌟Very interesting🌟 #CID #IDTwitter
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 8, 2020
The excessive vancomycin TDM for decades has been propagated w limitations in evidence & it should raise caution on contemporary vanco TDM recommendations @LucasTSchulz @Warren_E_Rose
Vancomycin:Just stop it already https://t.co/9JQbM9f8PW pic.twitter.com/e5cj4OpCvz
A new study in the Journal of the Pediatric Infectious Diseases Society describes what is believed to be the first case of resistant bacterial #meningitis in the #US. @CIDRAP https://t.co/9Q6eoDB0FJ
— AMR IndustryAlliance (@AMRAlliance) September 9, 2020
The southern hemisphere skipped #flu season in 2020.
— Microbes&Infection (@MicrobesInfect) September 10, 2020
Lockdowns to control the #coronavirus outbreak have all but eliminated #fluseason in the southern hemisphere.https://t.co/BkyGegTvhD #COVID19 #influenza
Jan 2020:
— Torr Leonard (@torrHL) September 10, 2020
“@ewarren releases plan to prevent and contain infectious diseases amid coronavirus outbreak”https://t.co/dNY71j1X38
Leading scientists and physicians including infectious diseases experts have warned that Victoria’s lockdown approach is not only destructive but likely to fail without a vaccine. https://t.co/UCBz0R79jS
— Rita Panahi (@RitaPanahi) September 9, 2020
Created by Cameron Forbes. Last updated September 19, 2020 at 05:08 EST.